NAD Recommends DERMADoctor Discontinue Claims Comparing Topical Lotion to Laser Treatments

New York, NY – Feb. 6, 2013 – The National Advertising Division has recommended that DERMADoctor discontinue advertising claims that state or suggest the company’s “Photodynamic Therapy Laser Lotion” offers the same benefits as physician-administered light treatments.

NAD found the company could continue to promote the lotion as a “moisturizer” and broad spectrum SPF 30 sunscreen.

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

Pursuant to its ongoing monitoring practice, NAD requested the advertiser provide support for claims that appeared in print advertising, including:

• “With Photodynamic Therapy you get the same anti-aging red light treatment without the hassle of cumbersome light gadgets, costly doctor visits or post-procedure downtime.”
• “Simply apply this lotion for all day anti-aging benefits, including restoring radiance, minimizing the appearance of fine lines and wrinkles, evening out skin tone and improving elasticity.”
• “Photodynamic Therapy is a red light treatment, daily moisturizer and broad spectrum SPF 30 all-in-one.”
• “It is the new reality in light therapy.”

Following its review of the evidence in the record, NAD determined that the company could promote the product as a moisturizer or sunscreen, but recommended the advertiser discontinue references to “light therapy” or “light treatment.”

NAD recommended the advertiser modify references to “restoring” radiance to better reflect the results of the advertiser’s clinical study.

The company, in its advertiser’s statement, said it “fully supports NAD’s mission and thanks NAD for the opportunity to work collaboratively with NAD in this matter.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary